Loading...
Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells
Cancer treatment, especially that for breast and lung cancer, has entered a new era and continues to evolve, with the development of genome analysis technology and the advent of molecular targeted drugs including tyrosine kinase inhibitors. Nevertheless, acquired drug resistance to molecular targete...
Na minha lista:
| Udgivet i: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676122/ https://ncbi.nlm.nih.gov/pubmed/31162771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14089 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|